GlaxoSmithKline is preparing to launch its smoking-cessation products in as many as 20 new emerging markets--including China, India and Russia--in another sign of the British drugmaker's desire to build sales in the developing world. Report [1]
Links:
[1] http://online.wsj.com/article/SB123663993183877143.html